Relationship of human leukocyte antigen class II genes with the susceptibility to hepatitis B virus infection and the response to interferon in HBV-infected patients

World Journal of Gastroenterology

Volumn 11, Issue 36, 2005, Pages 5721-5724

  Han, Yong Nian ^a   Yang, Jin Long ^a   Zhen, Shui Gen ^a   Tang, Qun ^a   Zhu, Wei ^a  

^a Shanghai 8th People's Hospital   (China)

Author keywords

Genetic susceptibility; Hepatitis B; Human leukocyte antigens; Interferon

Indexed keywords

ALPHA1 INTERFERON; HLA A2 ANTIGEN; SINOGEN;

ADULT; ALLELE; ARTICLE; BONE MARROW; CHINA; CONTROLLED STUDY; DNA FINGERPRINTING; DONOR; DRUG DOSE REGIMEN; DRUG RESPONSE; FEMALE; GENE FREQUENCY; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; INFECTION SENSITIVITY; MAJOR CLINICAL STUDY; MALE;

EID: 28044456571     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v11.i36.5721     Document Type: Article

References (16)

1. Hohler T, Gerken G, Notghi A, Lubjuhn R, Taheri H, Protzer U, Lohr HF, Schneider PM, Meyer zum Buschenfelde KH, Rittner C. HLA-DRB1*1301 and *1302 protect against chronic hepatitis B. J Hepatol 1997; 26: 503-507
2. Thio CL, Thomas DL, Karacki P, Gao X, Marti D, Kaslow RA, Goedert JJ, Hilgartner M, Strathdee SA, Duggal P, O'Brien SJ, Astemborski J, Carrington M. Comprehensive analysis of class I and class II HLA antigens and chronic hepatitis B virus infection. J Virol 2003; 77: 12083-12087
3. Ahn SH, Han KH, Park JY, Lee CK, Kang SW, Chon CY, Kim YS, Park K, Kim DK, Moon YM. Association between hepatitis B virus infection and HLA-DR type in Korea. Hepatology 2000; 31: 1371-1373
4. Wu YF, Wang LY, Lee TD, Lin HH, Hu CT, Cheng ML, Lo SY. HLA phenotypes and outcomes of hepatitis B virus infection in Taiwan. J Med Virol 2004; 72: 17-25
5. Meng XQ, Chen HG, Ma YL, Liu KZ. Influence of HLA class II molecules on the outcome of hepatitis B virus infection in population of Zhejiang Province in China. Hepatobiliary Pancreat Dis Int 2003; 2: 230-233
6. Jiang YG, Wang YM, Liu TH, Liu J. Association between HLA class II gene and susceptibility or resistance to chronic hepatitis B. World J Gastroenterol 2003; 9: 2221-2225
7. Shen JJ, Ji Y, Guan XL, Huang RJ, Sun YP. The association of HLA-DRB1*10 with chronic hepatitis B in Chinese patients. Linchuang Weishengwuxue Yu Mianyixue Zazhi 1999; 19: 58-59
8. Yu ML, Dai CY, Chen SC, Chiu CC, Lee LP, Lin ZY, Hsieh MY, Wang LY, Chuang WL, Cheng WY. Human leukocyte antigen class I and II alleles and response to interferon-alpha treatment, in Taiwanese patients with chronic hepatitis C virus infection. J Infect Dis 2003; 188: 62-65
9. Thio CL, Carrington M, Marti D, O'Brien SJ, Vlahov D, Nelson KE, Astemborski J, Thomas DL. Class II HLA alleles and hepatitis B virus persistence in African Americans. J Infect Dis 1999; 179: 1004-1006
10. Hyams KC. Risks of chronicity following acute hepatitis B virus infection: a review. Clin Infect Dis 1995; 20: 992-1000
11. Seeff LB, Beebe GW, Hoofnagle JH, Norman JE, Buskell-Bales Z, Waggoner JG, Kaplowitz N, Koff RS, Petrini JL Jr, Schiff ER. A serologic follow-up of the 1942epidemic of postvaccination hepatitis in the United States Army. N Engl J Med 1987; 316: 965-970
12. Luo KX. Hepatitis B: Basic Biology and Clinical Science. 2nd ed. Beijing: People's Hygiene Press 2001: 640-650
13. Qian Y, Zhang L, Liang XM, Hou JL, Luo KX. Association of immune response to hepatitis B vaccine with HLA-DRB1*02, 07, 09 genes in the population of Han nationality in Guangdong province. J Mil Med Univ 2002; 22: 67-69
14. Caillat-Zucman S, Gimenez JJ, Wambergue F, Albouze G, Lebkiri B, Naret C, Moynot A, Jungers P, Bach JF. Distinct HLA class II alleles determine antibody response to vaccination with hepatitis B surface antigen. Kidney Int 1998; 53: 1626-1630
15. Martinetti M, De Silvestri A, Belloni C, Pasi A, Tinelli C, Pistorio A, Salvaneschi L, Rondini G, Avanzini MA, Cuccia M. Humoral response to recombinant hepatitis B virus vaccine at birth: role of HLA and beyond. Clin Immunol 2000; 97: 234-240
16. Wai CT, Chu CJ, Hussain M, Lok AS. HBV genotype B is associated with better response to interferon therapy in HBeAg (+) chronic hepatitis than genotype C. Hepatology 2002; 36: 1425-1430